Aviva’s Helen of Troy HELE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,987
Closed -$2.11M 1029
2022
Q2
$2.11M Hold
12,987
0.01% 776
2022
Q1
$2.54M Hold
12,987
0.01% 739
2021
Q4
$3.17M Sell
12,987
-830
-6% -$197K 0.01% 684
2021
Q3
$3.1M Buy
13,817
+2,536
+22% +$580K 0.01% 688
2021
Q2
$2.57M Hold
11,281
0.01% 728
2021
Q1
$2.38M Sell
11,281
-2,389
-17% -$539K 0.01% 680
2020
Q4
$3.04M Hold
13,670
0.02% 590
2020
Q3
$2.65M Hold
13,670
0.02% 585
2020
Q2
$2.58M Sell
13,670
-3,456
-20% -$566K 0.02% 561
2020
Q1
$2.47M Sell
17,126
-743
-4% -$126K 0.02% 687
2019
Q4
$3.21M Hold
17,869
0.02% 565
2019
Q3
$2.82M Hold
17,869
0.02% 566
2019
Q2
$2.33M Buy
+17,869
New +$2.34M 0.02% 625

Other funds holding HELE

Aviva's HELE Position: Q3 2022 in Review

Aviva sold out of Helen of Troy (HELE) in Q3 2022, closing a stake of 12,987 shares — an estimated $2.11M sold.

Aviva first reported a position in HELE in Q2 2019 and held it in 13 quarters. The position peaked at $3.21M in Q4 2019. 256 funds tracked by Wall St. Rank hold HELE as of Q3 2022.

  • Aviva reported no remaining Helen of Troy position as of Q3 2022 after selling out during the quarter.
  • Aviva sold 12,987 Helen of Troy shares in Q3 2022, an estimated $2.11M.
  • Aviva first reported a position in Helen of Troy in Q2 2019 and held it in 13 quarters.
  • Aviva's Helen of Troy position peaked at $3.21M in Q4 2019.
  • 256 funds tracked by Wall St. Rank held Helen of Troy as of Q3 2022.

Based on Aviva's 13F filing for Q3 2022, filed 14 Nov 2022.